Bringing the fundamentals into focus…
Back to Dr. Reddy's Laboratories Limited
How Dr. Reddy's Laboratories Limited stacks up
RDY · against 152 other Healthcare companies of similar size
Valuation
51/ 100
Below the middle of the pack.
Ranked #83 of 153 · scores higher than 45% of peers
Bars: peers in each 10-point band of the valuation score24 peers with a valuation score of 50–59, including RDY · Click a bar to see the companies
Why valuation scores 51?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- EBITDA yield is close to the peer norm. EBITDA yield: 4.8% vs peer median 4.0%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 1.5% vs peer median 0.0%
- higher earnings for the price paid: stronger than 62% of peers. Earnings yield: 1.9% vs peer median 1.5%
Metric by metric
Position: dot = RDY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RDY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 151 reported | 2.9% | 2.6% | 55% | 30% | |
| EBITDA yieldHigher is better · 153 reported | 4.8% | 4.8% | 51% | 50% | |
| Free cash flow yieldHigher is better · 90 reported | 0.8% | 2.5% | 34% | 20% | |
| Book yieldHigher is better · 152 reported | Not reported | 19.8% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around RDY| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 4 | 21.5B USD | 95 | 60 | |
| 79 | 9.3B AUD (≈$6.1B) | 52 | 55 | |
| 79 | 21.7B USD | 52 | 32 | |
| 83 | 6.1B CHF (≈$7.0B) | 51 | 58 | |
| 83 | 18.5B USD | 51 | 62 | |
| 83 | 11.9B USD | 51 | 53 | |
| 86 | 558.5B INR (≈$6.7B) | 50 | 47 | |
| 86 | 521.3B INR (≈$6.3B) | 50 | 69 | |
| 86 | 9.0B USD | 50 | 78 | |
| 86 | 6.3B USD | 50 | 78 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score